- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic plaque psoriasis (CPP)
- Meeting Date: July 2026
Guselkumab – July 2026
- Injection 100 mg in 1 mL single use pre-filled pen
Public Summary Documents
Related Public Summary Documents
Last updated
12 November 2026
